IGVFFI1681PMGU

preview
validated
This object is in preview status. Metadata is subject to change until this object is released.
File Set
IGVFDS6874YIXA(prime editing Variant-EFFECTS)
Summary
R1 reads from sequencing run 1
File Format
fastq
Content Type
reads
Aliases
jesse-engreitz:Jurkat_Stim-IL2RA_prom-NegControl-PCRRep1_R1
md5sum
92ab2af5134444750a687cefbce9df8d
Content MD5sum
06af3b083bce6b9080671477a0d8ba70
File Size
6.8 KB
Submitted File Name
Jurkat_Stim-IL2RA_prom-BioRep2-FFRep3-PCRRep1-BinNeg_S193_R1_001.fastq.gz

Sequencing Details

Sequencing Platform
Sequencing Run
1
Illumina Read Type
R1
Index
CGTTACCA:CCTG
Average Read Length
150
Read Count
47

Samples

1 item
Accession
Type
Sample Terms
Summary
InVitroSystem
Jurkat cell line, male, Homo sapiens treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2)

Files Derived From This File

1 item
Accession
File Format
Content Type
Summary
Lab
File Size
Upload Status
tsv
variant effects
variant effects
Jesse Engreitz, Stanford
5.9 KB
validated

Attribution